Amyloid β-Protein (3-42)

This research-grade peptide, the pyroglutamate-modified Aβ (pEAβ (3-42) ), acts as a key amyloid template in Alzheimer's disease. It accelerates Aβ (1-42) aggregation and is utilized in vitro and in vivo to study amyloid nucleation mechanisms and neurotoxicity.